Hereditary Testing Market Size, Share & Trends Report

Hereditary Testing Market Size, Share & Trends Analysis Report By Disease Type (Hereditary Cancer Testing, Hereditary Non-cancer Testing), By Technology (Cytogenetic, Biochemical, Molecular Testing), By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-4-68038-999-9
Number of Pages: 270
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry: Healthcare

Market Segmentation

Hereditary Testing Market, Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hereditary Cancer Testing
  - Lung Cancer
  - Breast Cancer
  - Colorectal Cancer
  - Cervical Cancer
  - Ovarian Cancer
  - Prostate Cancer
  - Stomach/Gastric Cancer
  - Melanoma
  - Sarcoma
  - Uterine Cancer
  - Pancreatic Cancer
  - Others
- Hereditary Non-cancer Testing
  - Genetic Tests
    - Cardiac Diseases
    - Rare Diseases
    - Other Diseases
  - Preimplantation Genetic Diagnosis & Screening
  - Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
  - Newborn Genetic Screening
Hereditary Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Cytogenetic
- Biochemical
- Molecular Testing
Hereditary Testing Market, Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Hereditary Testing Market, By Disease Type
    - Hereditary Cancer Testing
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Ovarian Cancer
      - Prostate Cancer
      - Stomach/Gastric Cancer
      - Melanoma
      - Sarcoma
      - Uterine Cancer
      - Pancreatic Cancer
      - Others
    - Hereditary Non-cancer Testing
      - Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
      - Preimplantation Genetic Diagnosis & Screening
      - Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
      - Newborn Genetic Screening
  - North America Hereditary Testing Market, By Technology
    - Cytogenetic
    - Biochemical
    - Molecular Testing
  - U.S.
    - U.S. Hereditary Testing Market, By Disease Type
      - Hereditary Cancer Testing
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Ovarian Cancer
        
        Prostate Cancer
        
        Stomach/Gastric Cancer
        
        Melanoma
        
        Sarcoma
        
        Uterine Cancer
        
        Pancreatic Cancer
        
        Others
      - Hereditary Non-cancer Testing
        
        Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
        
        Preimplantation Genetic Diagnosis & Screening
        
        Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
        
        Newborn Genetic Screening
      - U.S. Hereditary Testing Market, By Technology
        
        Cytogenetic
        
        Biochemical
        
        Molecular Testing
  - Canada
    - Canada Hereditary Testing Market, By Disease Type
      - Hereditary Cancer Testing
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Ovarian Cancer
        
        Prostate Cancer
        
        Stomach/Gastric Cancer
        
        Melanoma
        
        Sarcoma
        
        Uterine Cancer
        
        Pancreatic Cancer
        
        Others
      - Hereditary Non-cancer Testing
        
        Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
        
        Preimplantation Genetic Diagnosis & Screening
        
        Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
        
        Newborn Genetic Screening
      - Canada Hereditary Testing Market, By Technology
        
        Cytogenetic
        
        Biochemical
        
        Molecular Testing
- Europe
  - Europe Hereditary Testing Market, By Disease Type
    - Hereditary Cancer Testing
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Ovarian Cancer
      - Prostate Cancer
      - Stomach/Gastric Cancer
      - Melanoma
      - Sarcoma
      - Uterine Cancer
      - Pancreatic Cancer
      - Others
    - Hereditary Non-cancer Testing
      - Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
      - Preimplantation Genetic Diagnosis & Screening
      - Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
      - Newborn Genetic Screening
  - Europe Hereditary Testing Market, By Technology
  - UK
    - UK Hereditary Testing Market, By Disease Type
      - Hereditary Cancer Testing
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Ovarian Cancer
        
        Prostate Cancer
        
        Stomach/Gastric Cancer
        
        Melanoma
        
        Sarcoma
        
        Uterine Cancer
        
        Pancreatic Cancer
        
        Others
      - Hereditary Non-cancer Testing
        
        Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
        
        Preimplantation Genetic Diagnosis & Screening
        
        Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
        
        Newborn Genetic Screening
    - UK Hereditary Testing Market, By Technology
      - Cytogenetic
      - Biochemical
      - Molecular Testing
    - Germany
      - Germany Hereditary Testing Market, By Disease Type
        
        Hereditary Cancer Testing
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Ovarian Cancer
        
        Prostate Cancer
        
        Stomach/Gastric Cancer
        
        Melanoma
        
        Sarcoma
        
        Uterine Cancer
        
        Pancreatic Cancer
        
        Others
        
        Hereditary Non-cancer Testing
        
        Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
        
        Preimplantation Genetic Diagnosis & Screening
        
        Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
        
        Newborn Genetic Screening
      - Germany Hereditary Testing Market, By Technology
        
        Cytogenetic
        
        Biochemical
        
        Molecular Testing
    - France
      - France Hereditary Testing Market, By Disease Type
        
        Hereditary Cancer Testing
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Ovarian Cancer
        
        Prostate Cancer
        
        Stomach/Gastric Cancer
        
        Melanoma
        
        Sarcoma
        
        Uterine Cancer
        
        Pancreatic Cancer
        
        Others
        
        Hereditary Non-cancer Testing
        
        Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
        
        Preimplantation Genetic Diagnosis & Screening
        
        Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
        
        Newborn Genetic Screening
      - France Hereditary Testing Market, By Technology
        
        Cytogenetic
        
        Biochemical
        
        Molecular Testing
    - Italy
      - Italy Hereditary Testing Market, By Disease Type
        
        Hereditary Cancer Testing
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Ovarian Cancer
        
        Prostate Cancer
        
        Stomach/Gastric Cancer
        
        Melanoma
        
        Sarcoma
        
        Uterine Cancer
        
        Pancreatic Cancer
        
        Others
        
        Hereditary Non-cancer Testing
        
        Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
        
        Preimplantation Genetic Diagnosis & Screening
        
        Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
        
        Newborn Genetic Screening
      - Italy Hereditary Testing Market, By Technology
        
        Cytogenetic
        
        Biochemical
        
        Molecular Testing
    - Spain
      - Spain Hereditary Testing Market, By Disease Type
        
        Hereditary Cancer Testing
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Ovarian Cancer
        
        Prostate Cancer
        
        Stomach/Gastric Cancer
        
        Melanoma
        
        Sarcoma
        
        Uterine Cancer
        
        Pancreatic Cancer
        
        Others
        
        Hereditary Non-cancer Testing
        
        Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
        
        Preimplantation Genetic Diagnosis & Screening
        
        Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
        
        Newborn Genetic Screening
      - Spain Hereditary Testing Market, By Technology
        
        Cytogenetic
        
        Biochemical
        
        Molecular Testing
    - Denmark
      - Denmark Hereditary Testing Market, By Disease Type
        
        Hereditary Cancer Testing
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Ovarian Cancer
        
        Prostate Cancer
        
        Stomach/Gastric Cancer
        
        Melanoma
        
        Sarcoma
        
        Uterine Cancer
        
        Pancreatic Cancer
        
        Others
        
        Hereditary Non-cancer Testing
        
        Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
        
        Preimplantation Genetic Diagnosis & Screening
        
        Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
        
        Newborn Genetic Screening
      - Denmark Hereditary Testing Market, By Technology
        
        Cytogenetic
        
        Biochemical
        
        Molecular Testing
    - Sweden
      - Sweden Hereditary Testing Market, By Disease Type
        
        Hereditary Cancer Testing
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Ovarian Cancer
        
        Prostate Cancer
        
        Stomach/Gastric Cancer
        
        Melanoma
        
        Sarcoma
        
        Uterine Cancer
        
        Pancreatic Cancer
        
        Others
        
        Hereditary Non-cancer Testing
        
        Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
        
        Preimplantation Genetic Diagnosis & Screening
        
        Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
        
        Newborn Genetic Screening
      - Sweden Hereditary Testing Market, By Technology
        
        Cytogenetic
        
        Biochemical
        
        Molecular Testing
    - Norway
      - Norway Hereditary Testing Market, By Disease Type
        
        Hereditary Cancer Testing
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Ovarian Cancer
        
        Prostate Cancer
        
        Stomach/Gastric Cancer
        
        Melanoma
        
        Sarcoma
        
        Uterine Cancer
        
        Pancreatic Cancer
        
        Others
        
        Hereditary Non-cancer Testing
        
        Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
        
        Preimplantation Genetic Diagnosis & Screening
        
        Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
        
        Newborn Genetic Screening
      - Norway Hereditary Testing Market, By Technology
        
        Cytogenetic
        
        Biochemical
        
        Molecular Testing
- Asia Pacific
  - Asia Pacific Hereditary Testing Market, By Disease Type
    - Hereditary Cancer Testing
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Ovarian Cancer
      - Prostate Cancer
      - Stomach/Gastric Cancer
      - Melanoma
      - Sarcoma
      - Uterine Cancer
      - Pancreatic Cancer
      - Others
    - Hereditary Non-cancer Testing
      - Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
      - Preimplantation Genetic Diagnosis & Screening
      - Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
      - Newborn Genetic Screening
  - Asia Pacific Hereditary Testing Market, By Technology
  - Japan
    - Japan Hereditary Testing Market, By Disease Type
      - Hereditary Cancer Testing
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Ovarian Cancer
        
        Prostate Cancer
        
        Stomach/Gastric Cancer
        
        Melanoma
        
        Sarcoma
        
        Uterine Cancer
        
        Pancreatic Cancer
        
        Others
      - Hereditary Non-cancer Testing
        
        Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
        
        Preimplantation Genetic Diagnosis & Screening
        
        Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
        
        Newborn Genetic Screening
    - Japan Hereditary Testing Market, By Technology
  - China
    - China Hereditary Testing Market, By Disease Type
      - Hereditary Cancer Testing
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Ovarian Cancer
        
        Prostate Cancer
        
        Stomach/Gastric Cancer
        
        Melanoma
        
        Sarcoma
        
        Uterine Cancer
        
        Pancreatic Cancer
        
        Others
      - Hereditary Non-cancer Testing
        
        Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
        
        Preimplantation Genetic Diagnosis & Screening
        
        Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
        
        Newborn Genetic Screening
    - China Hereditary Testing Market, By Technology
  - India
    - India Hereditary Testing Market, By Disease Type
      - Hereditary Cancer Testing
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Ovarian Cancer
        
        Prostate Cancer
        
        Stomach/Gastric Cancer
        
        Melanoma
        
        Sarcoma
        
        Uterine Cancer
        
        Pancreatic Cancer
        
        Others
      - Hereditary Non-cancer Testing
        
        Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
        
        Preimplantation Genetic Diagnosis & Screening
        
        Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
        
        Newborn Genetic Screening
    - India Hereditary Testing Market, By Technology
  - Australia
    - Australia Hereditary Testing Market, By Disease Type
      - Hereditary Cancer Testing
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Ovarian Cancer
        
        Prostate Cancer
        
        Stomach/Gastric Cancer
        
        Melanoma
        
        Sarcoma
        
        Uterine Cancer
        
        Pancreatic Cancer
        
        Others
      - Hereditary Non-cancer Testing
        
        Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
        
        Preimplantation Genetic Diagnosis & Screening
        
        Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
        
        Newborn Genetic Screening
    - Australia Hereditary Testing Market, By Technology
  - South Korea
    - South Korea Hereditary Testing Market, By Disease Type
      - Hereditary Cancer Testing
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Ovarian Cancer
        
        Prostate Cancer
        
        Stomach/Gastric Cancer
        
        Melanoma
        
        Sarcoma
        
        Uterine Cancer
        
        Pancreatic Cancer
        
        Others
      - Hereditary Non-cancer Testing
        
        Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
        
        Preimplantation Genetic Diagnosis & Screening
        
        Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
        
        Newborn Genetic Screening
    - South Korea Hereditary Testing Market, By Technology
      - Cytogenetic
      - Biochemical
      - Molecular Testing
  - Thailand
    - Thailand Hereditary Testing Market, By Disease Type
      - Hereditary Cancer Testing
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Ovarian Cancer
        
        Prostate Cancer
        
        Stomach/Gastric Cancer
        
        Melanoma
        
        Sarcoma
        
        Uterine Cancer
        
        Pancreatic Cancer
        
        Others
      - Hereditary Non-cancer Testing
        
        Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
        
        Preimplantation Genetic Diagnosis & Screening
        
        Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
        
        Newborn Genetic Screening
    - Thailand Hereditary Testing Market, By Technology
- Latin America
  - Latin America Hereditary Testing Market, By Disease Type
    - Hereditary Cancer Testing
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Ovarian Cancer
      - Prostate Cancer
      - Stomach/Gastric Cancer
      - Melanoma
      - Sarcoma
      - Uterine Cancer
      - Pancreatic Cancer
      - Others
    - Hereditary Non-cancer Testing
      - Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
      - Preimplantation Genetic Diagnosis & Screening
      - Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
      - Newborn Genetic Screening
  - Latin America Hereditary Testing Market, By Technology
  - Brazil
    - Brazil Hereditary Testing Market, By Disease Type
      - Hereditary Cancer Testing
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Ovarian Cancer
        
        Prostate Cancer
        
        Stomach/Gastric Cancer
        
        Melanoma
        
        Sarcoma
        
        Uterine Cancer
        
        Pancreatic Cancer
        
        Others
      - Hereditary Non-cancer Testing
        
        Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
        
        Preimplantation Genetic Diagnosis & Screening
        
        Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
        
        Newborn Genetic Screening
    - Brazil Hereditary Testing Market, By Technology
  - Mexico
    - Mexico Hereditary Testing Market, By Disease Type
      - Hereditary Cancer Testing
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Ovarian Cancer
        
        Prostate Cancer
        
        Stomach/Gastric Cancer
        
        Melanoma
        
        Sarcoma
        
        Uterine Cancer
        
        Pancreatic Cancer
        
        Others
      - Hereditary Non-cancer Testing
        
        Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
        
        Preimplantation Genetic Diagnosis & Screening
        
        Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
        
        Newborn Genetic Screening
    - Mexico Hereditary Testing Market, By Technology
  - Argentina
    - Argentina Hereditary Testing Market, By Disease Type
      - Hereditary Cancer Testing
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Ovarian Cancer
        
        Prostate Cancer
        
        Stomach/Gastric Cancer
        
        Melanoma
        
        Sarcoma
        
        Uterine Cancer
        
        Pancreatic Cancer
        
        Others
      - Hereditary Non-cancer Testing
        
        Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
        
        Preimplantation Genetic Diagnosis & Screening
        
        Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
        
        Newborn Genetic Screening
    - Argentina Hereditary Testing Market, By Technology
- MEA
  - MEA Hereditary Testing Market, By Disease Type
    - Hereditary Cancer Testing
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Ovarian Cancer
      - Prostate Cancer
      - Stomach/Gastric Cancer
      - Melanoma
      - Sarcoma
      - Uterine Cancer
      - Pancreatic Cancer
      - Others
    - Hereditary Non-cancer Testing
      - Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
      - Preimplantation Genetic Diagnosis & Screening
      - Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
      - Newborn Genetic Screening
  - MEA Hereditary Testing Market, By Technology
  - South Africa
    - South Africa Hereditary Testing Market, By Disease Type
      - Hereditary Cancer Testing
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Ovarian Cancer
        
        Prostate Cancer
        
        Stomach/Gastric Cancer
        
        Melanoma
        
        Sarcoma
        
        Uterine Cancer
        
        Pancreatic Cancer
        
        Others
      - Hereditary Non-cancer Testing
        
        Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
        
        Preimplantation Genetic Diagnosis & Screening
        
        Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
        
        Newborn Genetic Screening
    - South Africa Hereditary Testing Market, By Technology
  - Saudi Arabia
    - Saudi Arabia Hereditary Testing Market, By Disease Type
      - Hereditary Cancer Testing
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Ovarian Cancer
        
        Prostate Cancer
        
        Stomach/Gastric Cancer
        
        Melanoma
        
        Sarcoma
        
        Uterine Cancer
        
        Pancreatic Cancer
        
        Others
      - Hereditary Non-cancer Testing
        
        Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
        
        Preimplantation Genetic Diagnosis & Screening
        
        Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
        
        Newborn Genetic Screening
    - Saudi Arabia Hereditary Testing Market, By Technology
  - UAE
    - UAE Hereditary Testing Market, By Disease Type
      - Hereditary Cancer Testing
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Ovarian Cancer
        
        Prostate Cancer
        
        Stomach/Gastric Cancer
        
        Melanoma
        
        Sarcoma
        
        Uterine Cancer
        
        Pancreatic Cancer
        
        Others
      - Hereditary Non-cancer Testing
        
        Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
        
        Preimplantation Genetic Diagnosis & Screening
        
        Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
        
        Newborn Genetic Screening
    - UAE Hereditary Testing Market, By Technology
  - Kuwait
    - Kuwait Hereditary Testing Market, By Disease Type
      - Hereditary Cancer Testing
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Ovarian Cancer
        
        Prostate Cancer
        
        Stomach/Gastric Cancer
        
        Melanoma
        
        Sarcoma
        
        Uterine Cancer
        
        Pancreatic Cancer
        
        Others
      - Hereditary Non-cancer Testing
        
        Genetic Tests
        
        Cardiac Diseases
        
        Rare Diseases
        
        Other Diseases
        
        Preimplantation Genetic Diagnosis & Screening
        
        Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
        
        Newborn Genetic Screening
    - Kuwait Hereditary Testing Market, By Technology
      - Cytogenetic
      - Biochemical
      - Molecular Testing

Hereditary Testing Market Dynamics

Driver: Growing demand and sales for DNA test kits

A consistent increase in demand for newborn screening has led to an increase in sales of DNA testing kits. For instance, the Division of Consolidated Laboratory Services (DCLS) of the Virginia Department of General Services screened 7,868 newborn babies for nearly 31 hereditary and metabolic disorders in November 2019. DCLS performs nearly 4 million newborn screening tests on around 120,000 samples annually. In addition, all 50 states of the U.S. have their newborn screening programs. Thus, nearly every newborn child in the U.S. is screened for hereditary disorders, with a state participation rate of 99.9% or more. WHO estimates suggest that 1 in every 2000 to 3000 newborns is affected by Cystic Fibrosis (CF) in the EU, while in the U.S., the incidence of CF is reported to be 1 in every 3500 births. The adoption of advanced technologies, such as tandem mass spectrometry, microarrays, proteomics, nanotechnology, and DNA chip technology has increased the accuracy of test results, thus enhancing sales of testing kits for hereditary disorders. To meet the high demand, key players have launched advanced tests to sustain market competition. Novel platforms utilize a combination of sequencing technologies, PCR, and proprietary algorithms for the analysis of Cell-free Fetal DNA (cffDNA) to detect chromosomal aneuploidies, such as Down’s syndrome, Edwards’ syndrome, and Patau syndrome.

Restraint: Clinical and ethical issues pertaining to DNA tests

The presence of ethical issues about the safety of in-vitro fertilization and Preimplantation genetic diagnosis (PGD) is expected to hamper market growth. PGD is morally unacceptable to several people and cultures as it is considered an unnatural creation and involves the destruction of the human embryo. Application of these tests for sex selection on nonmedical backgrounds is also prohibited in several countries, which is expected to restrain application demand and market growth. Furthermore, high implementation and procurement costs are major restraints in developing economies. The absence of an appropriate framework for insurance coverage and the accessibility of these tests are other factors expected to restrain growth. Miscoding, overbilling, and subsequent overpayment for genetic tests by insurance providers are further expected to hamper market growth.

Opportunity: Rising prevalence of genetic diseases

Although genetic diseases have a relatively lower incidence than several key pathogenic diseases, they affect a significant number of people worldwide. A steady growth in the incidence of different genetic disorders can drive demand for genetic diagnostics, as they are becoming more effective in screening, diagnosing, and preventing a broad range of pathogenic & nonpathogenic diseases. Early detection of multiple common genetic diseases has proven instrumental in reducing the number of people suffering from congenital disorders. This is expected to increase the number of people undergoing IVF to opt for PGD cycles. Furthermore, the application of HLA typing in combination with stem cell therapy, including the adoption of IVF to bear a savior sibling to treat the first child suffering from a genetic disorder, is anticipated to drive market demand.

What Does This Report Include?

This section will provide insights into the contents included in this hereditary testing market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Hereditary Testing market qualitative analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Hereditary Testing market quantitative analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.